KRAS Gene Leukemia Acute Myelogenous NGS Genetic DNA Test
Comprehensive Genetic Analysis for Acute Myeloid Leukemia
The KRAS Gene Leukemia Acute Myelogenous NGS Genetic DNA Test represents a breakthrough in precision oncology, offering detailed genetic insights into one of the most critical drivers of acute myeloid leukemia (AML). This advanced diagnostic tool utilizes next-generation sequencing technology to identify specific mutations in the KRAS gene that play a pivotal role in leukemia development and progression.
What Does This Test Measure and Detect?
This sophisticated genetic test specifically targets and analyzes the KRAS (Kirsten rat sarcoma viral oncogene homolog) gene, which encodes a crucial protein involved in cell signaling pathways. The test detects:
- Point mutations in the KRAS gene coding regions
- Specific amino acid substitutions (particularly at codons 12, 13, and 61)
- Activating mutations that drive uncontrolled cell proliferation
- Genetic alterations associated with treatment resistance
- Mutation burden and variant allele frequency
Who Should Consider This Test?
This genetic test is recommended for individuals experiencing:
- Unexplained fatigue, weakness, or persistent fever
- Frequent infections or unusual bleeding/bruising
- Diagnosis of acute myeloid leukemia requiring genetic profiling
- Family history of blood cancers or hematological malignancies
- Poor response to standard leukemia treatments
- Need for targeted therapy selection and personalized treatment planning
- Monitoring of disease progression or treatment response
Key Benefits of KRAS Genetic Testing
- Precision Diagnosis: Provides definitive genetic confirmation of AML subtypes
- Treatment Guidance: Helps select appropriate targeted therapies and clinical trials
- Prognostic Information: Offers insights into disease aggressiveness and expected outcomes
- Early Detection: Identifies genetic markers before clinical symptoms manifest
- Family Risk Assessment: Assists in evaluating hereditary cancer risks
- Monitoring Capability: Enables tracking of treatment response and minimal residual disease
Understanding Your Test Results
Your KRAS gene test results will be carefully interpreted by our expert genetic counselors and oncologists:
- Positive for KRAS Mutation: Indicates the presence of genetic alterations associated with AML, guiding targeted treatment approaches
- Negative Result: Suggests absence of detectable KRAS mutations, potentially indicating other genetic drivers of leukemia
- Variant of Uncertain Significance: Requires additional clinical correlation and possibly further testing
- Mutation Burden: Provides quantitative information about the proportion of mutated cells
All results include detailed interpretation and recommendations for next steps in your care plan.
Test Details and Pricing
| Test Information | Details |
|---|---|
| Test Name | KRAS Gene Leukemia Acute Myelogenous NGS Genetic DNA Test |
| Discount Price | $500 USD |
| Regular Price | $700 USD |
| Turnaround Time | 3 to 4 Weeks |
| Sample Type | Blood, Extracted DNA, or One Drop Blood on FTA Card |
| Specialty | Oncology Genetics |
| Testing Method | Next-Generation Sequencing (NGS) |
Pre-Test Requirements
Before undergoing testing, we recommend:
- Complete clinical history documentation
- Genetic counseling session with our certified genetic counselors
- Development of a detailed family pedigree chart
- Discussion of potential implications and insurance coverage
- Informed consent process
Nationwide Availability
We have testing facilities conveniently located across the United States, including major metropolitan areas such as New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, Austin, Jacksonville, Fort Worth, Columbus, Charlotte, San Francisco, Indianapolis, Seattle, Denver, Washington DC, Boston, El Paso, Nashville, Detroit, Oklahoma City, Portland, Las Vegas, Memphis, Louisville, Baltimore, and Milwaukee.
Take Control of Your Health Today
Don’t wait to get the critical genetic information you need for informed cancer care decisions. Our KRAS Gene Leukemia Acute Myelogenous NGS Genetic DNA Test provides the comprehensive genetic analysis required for modern precision oncology.
Call or WhatsApp us now at +1(267) 388-9828 to schedule your genetic counseling session and book your test. Our dedicated team is ready to assist you with scheduling, insurance questions, and any concerns you may have about the testing process.
Early genetic testing can make a significant difference in treatment outcomes and quality of life. Take the first step toward personalized cancer care today.
